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LETTER TO THE EDITOR
Patient Blood Management:
where to start?
consultation,  as  well  as  treat  him  (for  such,  it  is  worth
reading  these  two  good  articles  on  how  to  manage  an
anemic  patient  during  the  pre-anesthetic  visit).5,6 Within
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reduced costs after cardiac surgery. J Thorac Cardiovasc Surg.
2013;145:796--803.Patient Blood Management: por onde
comec¸ar?
Dear  Editor,
Most  anesthesiologists  recognize  the  harmful  effects  of
transfusion  therapy  and  try  to  avoid  exposure  to  allogeneic
blood,  although  some  of  them  decidedly  have  no  interested
in  the  subject  and  perform  transfusion  without  physiological
or  even  laboratory  criteria.  However,  it  is  likely  that  there
are  anesthesiologists  who  have  never  transfused  one  bag  of
packed  red  blood  cells  (RBCs)  and/or  fresh  frozen  plasma
and  this  makes  the  subject  blood  transfusion  quite  relevant
and  generally  controversial.
Blood  is  the  most  transfused  organ  in  the  world,  with
about  14  million  units  of  packed  RBCs  transfused  each  year,
which  represents  a  cost  of  approximately  US  $3  billion  (aver-
age  of  $225  per  RBCs).1 Having  in  your  hospital  a  program
that  combats  this  ‘‘need’’  for  blood  transfusion  can  improve
patient  outcomes,  minimize  risk,  and  reduce  costs.  In  this
sense,  the  term  Patient  Blood  Management  (PBM)  was  cre-
ated,  which  consists  of  applying  a  multidisciplinary  approach
based  on  medical  evidence  and  surgical  concepts  that  is  hos-
pital  independent  and  patient-centered  for  early  diagnosis
and  treatment  of  anemia,  application  of  blood  conservation
techniques,  careful  surgical  hemostasis,  and  rational  use  of
blood  products  in  order  to  improve  above  all  the  patient’s
prognosis.  Since  2010,  the  World  Health  Organization  rec-
ommended  the  application  of  PMB  as  a  strategy  for  reducing
the  number  of  RBCs  transfusions  worldwide.2
And  why  start  using  such  a  program?  Statistical  data
provide  the  answer.  Hospital  stay  of  non-transfused  patients
is  on  average  25%  lower  than  that  of  transfused  patients.3
Studies  show  that  the  implementation  of  a  transfusion
strategy  program  in  heart  surgery  reduces  death  rate  by
47%  and  post-surgical  hospital  costs  by  50%.4 However,  the
point  considered  more  important  and  in  which  probably  all
anesthesiologists  can  act  in  a  simple  and  very  effective
way  is  the  management  of  preoperative  anemia.  It  is  very
easy  to  diagnose  an  anemic  patient  in  a  pre-anesthetic
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0104-0014/© 2015 Sociedade Brasileira de Anestesiologia. Published by E very  reasonable  period  of  15--20  days  we  can  manage
he  anemic  condition  of  the  patient  and  he  may  undergo
urgery  within  acceptable  limits.  And  that  makes  all  the
ifference,  as  preoperative  anemia  is  directly  related  to
ed  blood  cell  transfusion  during  surgery,  which  is  a  cause
f  increased  morbidity  and  postoperative  mortality.7--9
he  preoperative  diagnosis  and  appropriate  treatment
f  anemia  reduce  the  incidence  of  transfusion  by  62%.10
any  of  us,  anesthesiologists,  believe  that  anemia  is  not
s  frequent  or  is  harmless,  but  according  to  the  World
ealth  Organization  data  there  are  more  than  two  billion
nemic  people  worldwide.11 On  average,  15--40%  of  patients
ave  anemia  at  the  time  of  surgery  and,  according  to  the
oncepts  of  PBM,  anemia  is  a  contraindication  to  elective
urgery,  with  an  expected  moderate  to  severe  blood  loss.12
So,  here  is  a  proposal  and  a  challenge:  anemia  should
e  diagnosed  and  treated  before  surgery.  That  alone  is  the
rst  and  major  step  to  reduce  blood  transfusion,  which  will
reatly  beneﬁt  the  patient  and  improve  the  quality  of  our
nesthesia.
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